129 related articles for article (PubMed ID: 3729311)
1. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
Koski CL; Gratz E; Sutherland J; Mayer RF
Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
[TBL] [Abstract][Full Text] [Related]
3. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
4. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.
Koski CL; Humphrey R; Shin ML
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):905-9. PubMed ID: 3856240
[TBL] [Abstract][Full Text] [Related]
5. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
6. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
Vedeler CA; Nyland H
Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.
Vriesendorp FJ; Mayer RF; Koski CL
Arch Neurol; 1991 Aug; 48(8):858-61. PubMed ID: 1898263
[TBL] [Abstract][Full Text] [Related]
10. [Antiglycolipid antibody in inflammatory neuropathy].
Kusunoki S
Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
[TBL] [Abstract][Full Text] [Related]
11. Humoral mechanisms in immune neuropathies.
Koski CL
Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
[TBL] [Abstract][Full Text] [Related]
12. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
Nomura K
Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
[TBL] [Abstract][Full Text] [Related]
13. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
14. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
15. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
[TBL] [Abstract][Full Text] [Related]
17. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
[TBL] [Abstract][Full Text] [Related]
19. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
Ariga T; Yu RK
J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
[TBL] [Abstract][Full Text] [Related]
20. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
Brown MJ; Rosen JL; Lisak RP
Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
